middle.news
Clinuvel Targets December 2026 for Vitiligo Trial Results
8:56am on Tuesday 28th of July, 2026 AEST
•
Healthcare
Read Story
Clinuvel Targets December 2026 for Vitiligo Trial Results
8:56am on Tuesday 28th of July, 2026 AEST
Key Points
CUV105 vitiligo trial topline results expected December 2026
SCENESSE® assessed alongside standard narrowband UVB phototherapy
EMA endorses Phase III CUV107 study design with 300 patients
Phase III trial recruitment planned to start November 2026
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Clinuvel Pharmaceuticals (ASX:CUV)
OPEN ARTICLE